WebMD - September 13, 2021
Charles Hall, Ph.D., comments on his research that found first responders to the World Trade Center site on 9/11 have increased risk of certain cancers, including prostate cancer, which has been detected earlier than expected. Dr. Hall is professor of epidemiology & population health and in the Saul R. Korey Department of Neurology at Einstein.
Additional coverage includes: Yahoo News and MedPage Today (login required)
Dr. Hall's ProfileMore coverage on Dr. Hall
Scientific American - September 10, 2021
Rachel Zeig-Owens, Dr.P.H., discusses her research on FDNY first responders to the 9/11 terrorist attack, including findings that those who arrived at the World Trade Center site earliest have the highest rates of respiratory disease. Dr. Zeig-Owens is assistant professor of epidemiology & population health at Einstein and director of epidemiology and the lead epidemiologist for the World Trade Center Health Program at the Fire Department of the City of New York.
Additional Coverage includes The Scientist, NPR
Dr. Zeig-Owens' Profile
Nature - September 7, 2021
Betsy Herold, M.D. comments on her study that found children mount a stronger innate immune response to COVID-19 compared to adults, which helps them eliminate the virus' threat. Dr. Herold is chief of infectious diseases and vice chair for research in the department of pediatrics at Einstein and Children's Hospital at Montefiore and the Harold and Muriel Block Chair in Pediatrics at Einstein.
Dr. Herold's ProfileMore coverage on Dr. Herold
National Institute on Aging - September 2, 2021
Ana Maria Cuervo, M.D., Ph.D. and Evripidis Gavathiotis, Ph.D., developed an experimental drug that reinvigorates a cellular cleaning mechanism and reversed key symptoms of Alzheimer's disease in mice. Dr. Cuervo is professor of developmental and molecular biology, co-director of the Institute for Aging Research, and holds the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Einstein. Dr. Gavathiotis is professor of biochemistry and of medicine.
Dr. Cuervo's ProfileMore coverage on Dr. Cuervo
The Wall Street Journal - August 15, 2021
Research led by Alexander Sankin, M.D., and Einstein medical student Joseph Kim, found that a type of immunotherapy given to patients with non-muscle-invasive bladder cancer was associated with a reduced risk for developing Alzheimer's disease compared to those who did not receive the drug. The Wall Street Journal cited the study in an article exploring a possible connection between vaccines and Alzheimer's. Dr. Sankin is associate professor of urology at Einstein and a surgeon at Montefiore.
Dr. Sankin's Profile
Tampa Bay Times - August 14, 2021
Carol Bernstein, M.D., says medical workers may experience mental health issues—from short-term problems with eating and sleeping to chronic anxiety disorder and longlasting depression—as a result of caring for yet another surge of severely ill COVID-19 patients. Dr. Bernstein is professor of psychiatry and behavioral sciences and of obstretrics & gynecology and women's health at Einstein and a clinical psychiatrist at Montefiore.
Dr. Bernstein's Profile
City and State NY - August 1, 2021
Philip Ozuah, M.D., Ph.D., and Gordon Tomaselli, M.D., jointly ranked #13 in this list of leaders cultivating New York City's fast-growing biotech and life sciences hub. Dr. Ozuah is president and CEO of Montefiore Medicine and Dr. Tomaselli is the Marilyn and Stanley M. Katz Dean at Einstein and executive vice president and chief academic officer at Montefiore Medicine.
Dr. Ozuah's Profile
ABC News - July 21, 2021
Panagiota Korenis, M.D., discusses both problems and potential benefits of using ketamine for treating people with depression. Dr. Korenis is associate professor of psychiatry and behavioral sciences at Einstein.
Dr. Korenis' Profile
New York Post - July 20, 2021
Nir Barzilai, M.D., talks about his plans for a clinical trial to study metformin, a diabetes drug, to target age-related diseases. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Medscape - July 19, 2021
Matthew Akiyama, M.D., describes his National Institutes of Health award to use new sequencing technology to understand HIV and hepatitis C transmission, which may lead to new prevention and treatment strategies for the diseases. Dr. Akiyama is associate professor of medicine at Einstein and an internist at Montefiore.
Dr. Akiyama's ProfileMore coverage on Dr. Akiyama
Science News - July 14, 2021
Suzette Olu Bousola Oyeku, M.D., M.P.H., comments on the significant increase in the number of children worldwide who have missed vaccinations for preventable diseases like measles, diphtheria, tetanus, and pertussis, and warns that clusters of outbreaks could occur as a result. Dr. Oyeku is professor of pediatrics at Einstein and chief of the division of academic general pediatrics at the Children’s Hospital at Montefiore (CHAM).
Dr. Oyeku's Profile
Medscape - July 9, 2021
Priya Nori, M.D., discusses the disagreement between Pfizer and the Centers for Disease Control about COVID-19 booster shots, and says a more important issue is vaccine equity and the need to provide initial shots for healthcare workers in low- and middle-income countries. Dr. Nori is associate professor of medicine and of orthopaedic surgery at Einstein and Montefiore.
Dr. Nori's ProfileMore coverage on Dr. Nori
National Institute on Aging - July 8, 2021
Carol Derby, Ph.D., led research in the National Institutes of Health-supported Study of Women's Health Across the Nation (SWAN) that found heart disease risk factors, such as high blood pressure, diabetes, and belly fat, were associated with declines in cognitive processing speed during midlife. Dr. Derby is research professor in the Saul R. Korey Department of Neurology and in the department of epidemiology & population health and is the Louis and Gertrude Feil Faculty Scholar in Neurology at Einstein. She is principal investigator of the Einstein site of the SWAN study underway at seven clinical centers across the United States.
Dr. Derby's Profile
The Scientist - July 1, 2021
Libusha Kelly, Ph.D., describes SARS-CoV-2 sequencing efforts at Einstein and Montefiore and calls for a robust national genomic sequencing program to help scientists detect, understand, and stay ahead of new and developing viral variants. Dr. Kelly is associate professor of systems & computational biology and of microbiology & immunology.
Dr. Kelly's ProfileMore coverage on Dr. Kelly
Nature - September 2, 2020
In a commentary for Nature, Gary Schwartz, Ph.D., writes about the discovery of a pathway in the preoptic area of the brain in mice by which a light-sensitive protein regulates heat production. The findings may lead to ways of altering metabolism by manipulating environmental light. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is chair of ophthalmology & vision services at Einstein and Montefiore Medical Center.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion